Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Annals of Clinical and Laboratory Science|December 22, 2017
Elevated Expression of DLG1 Is Associated with Poor Prognosis in Patients with Colorectal CancerGuo-Dong Zhu, Shi OuYang, Feng Liu, et al.
Biochemical and Biophysical Research Communications|February 27, 2018
BACH1 promotes the progression of human colorectal cancer through BACH1/CXCR4 pathwayGuo-Dong Zhu, Feng Liu, Shi OuYang, et al.
Zhonghua Nan Ke Xue = National Journal of Andrology|October 1, 2017
[Correlation of oxidative stress with sperm DNA integrity and semen parameters in infertile men with varicocele]Hao Fu, Wen-Ke Song, Xiao-Hui Ling, et al.
Oncotargets and Therapy|July 30, 2016
Decreased expression of SLC 39A14 is associated with tumor aggressiveness and biochemical recurrence of human prostate cancerXiao-Ming Xu, Cheng-Gong Wang, Yu-Di Zhu, et al.
Current Cancer Drug Targets|June 16, 2022
Genome-Wide CRISPR-Cas9 Screening and Identification of Potential Genes Promoting Prostate Cancer Growth and MetastasisWei Wang, Dongbo Yuan, Kehua Jiang, et al.
Bioengineered|January 26, 2023
CRISPR/Cas9 (D10A) nickase-mediated Hb CS gene editing and genetically modified fibroblast identificationWei-Hao Wu, Xiao-Mei Ma, Jian-Qing Huang, et al.
Oncology Letters|August 22, 2018
Overexpression of TPX2 is associated with progression and prognosis of prostate cancerJun Zou, Rui-Yan Huang, Fu-Neng Jiang, et al.
Oncology Letters|March 22, 2016
BCL9, a coactivator for Wnt/β-catenin transcription, is targeted by miR-30c and is associated with prostate cancer progressionXiao-Hui Ling, Zhi-Yun Chen, Hong-Wei Luo, et al.
Pathology, Research and Practice|November 30, 2019
Increasing of FKBP9 can predict poor prognosis in patients with prostate cancerFu-Neng Jiang, Li-Jun Dai, Sheng-Bang Yang, et al.
Pathology Oncology Research : POR|March 5, 2013
MicroRNA-335 acts as a candidate tumor suppressor in prostate cancerSi-wei Xiong, Tian-xin Lin, Ke-wei Xu, et al.
Pageof 4